Skip to content
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
    All
      10
        Filing date Form Description View
        Nov 12, 2024 SC 13G/A An amendment to the SC 13G filing
        Nov 12, 2024 SC 13G A statement of beneficial ownership of common stock by certain persons
        Nov 12, 2024 4 Statement of changes in beneficial ownership of securities
        Nov 12, 2024 4 Statement of changes in beneficial ownership of securities
        Nov 08, 2024 SC 13G/A An amendment to the SC 13G filing
        Nov 08, 2024 SC 13G/A An amendment to the SC 13G filing
        Nov 07, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
        Nov 07, 2024 SC 13G/A An amendment to the SC 13G filing
        Nov 06, 2024 8-K Report of unscheduled material events or corporate event
        Nov 06, 2024 10-Q Quarterly report which provides a continuing view of a company's financial position
        Pagination
        • First page «
        • Previous page ‹
        • …
        • Page 3
        • Page 4
        • Current page 5
        • Page 6
        • Page 7
        • …
        • Next page ›
        • Last page »
        Displaying 41 - 50 of 696 results

        Sign up for email alerts

        Stay in the loop with updates on the latest Denali news delivered right to your inbox


        • Investor & Media Relations

        CONTACT US

        161 Oyster Point Blvd- South San Francisco, CA 94080

        © 2025 Denali Therapeutics

        • Privacy Policy
        • Terms of Use

        ©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

        • Privacy Policy
        • Terms of Use

        We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so.